Search...
FUSEN PHARM: Metformin and Ertugliflozin Tablets (I) intends to win the bid for the 11th batch of national centralized drug procurement in China
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, FUSEN PHARM announced that one of its products is expected to win the bid in the results of China's 11th national centralized drug procurement tender on October 27, 2025: Metformin and Ertugliflozin Tablets (I) (500mg Metformin Hydrochloride and 5mg Ertugliflozin)
According to the announcement from Dolphin Research, FUSEN PHARM (01652) stated that one of the group's products is expected to win the bid in the results of China's 11th batch of national centralized drug procurement on October 27, 2025: Metformin and Ertugliflozin Tablets (I) (500mg Metformin Hydrochloride and 5mg Ertugliflozin)
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments